CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 256 filers reported holding CYTOKINETICS INC in Q3 2023. The put-call ratio across all filers is 2.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $632,447 | +66.0% | 21,468 | +11.4% | 0.02% | -50.0% |
| Q2 2021 | $381,000 | -43.4% | 19,266 | -38.0% | 0.03% | -25.6% |
| Q3 2020 | $673,000 | -31.8% | 31,092 | -25.7% | 0.04% | -37.7% |
| Q2 2020 | $987,000 | +26.5% | 41,873 | -36.7% | 0.07% | +21.1% |
| Q1 2020 | $780,000 | +140.0% | 66,125 | +115.9% | 0.06% | +200.0% |
| Q4 2019 | $325,000 | +16.9% | 30,632 | -30.4% | 0.02% | +11.8% |
| Q4 2018 | $278,000 | +135.6% | 44,016 | +204.2% | 0.02% | +30.8% |
| Q4 2017 | $118,000 | -22.9% | 14,470 | +37.1% | 0.01% | -66.7% |
| Q3 2017 | $153,000 | -15.5% | 10,556 | -29.3% | 0.04% | -22.0% |
| Q2 2017 | $181,000 | -77.4% | 14,931 | -76.1% | 0.05% | -51.5% |
| Q1 2017 | $802,000 | +1.3% | 62,381 | -44.5% | 0.10% | +10.8% |
| Q1 2016 | $792,000 | +109.5% | 112,403 | +99.7% | 0.09% | +121.4% |
| Q2 2015 | $378,000 | – | 56,300 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
| Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
| Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
| Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
| GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
| Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
| PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
| DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
| Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
| Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |